Sustainability in the Manufacturing of Pharmaceuticals

See the new book, edited by Dimitrios A. Lamprou. This book compiles cutting-edge research from leading global experts, offering scientific insights and innovative strategies to revolutionize sustainability in pharmaceuticals.

Key Features

Covers the importance of sustainability in the pharmaceutical sector
Discusses new manufacturing methods as key elements to make the sector more sustainable
Provides a dedicated chapter on regulatory aspects

Description: Sustainability in Pharmaceutical Manufacturing is a groundbreaking reference for the pharmaceutical industry. Currently lagging behind other manufacturing sectors, pharmaceutical production requires significant changes in areas such as manufacturing methods, waste management, packaging, and supply chain. This book compiles cutting-edge research from leading global experts, offering scientific insights and innovative strategies to revolutionize sustainability in pharmaceuticals. It explores the transformative potential of the circular economy, lifecycle management, and resource optimization for maximum efficiency and minimal environmental impact.

The book delves into green chemistry, highlighting alternative solvents and methods for drug production. It emphasizes novel microfluidic and additive manufacturing techniques, utilizing bio-based sustainable polymers and materials. Chapters on greener drug discovery, development, and scaling processes provide the most current research at each production stage. This invaluable resource enables researchers in academia and industry to make informed choices, enhancing their manufacturing practices and shaping the future of sustainability in the pharmaceutical sector.

This chapter delineates the evolving culture of sustainability within pharmaceutical manufacturing, highlighting the convergence of ethical responsibility, regulatory compliance, market forces, and emerging technologies that drive sustainable practices. Traditional environmental concerns have broadened to encompass waste minimization, energy conservation, and socially responsible operations. International policy initiatives, such as the European Green Deal and the United Nations Sustainable Development Goals, have incentivized greener manufacturing, spurring companies to adopt holistic strategies that address sustainability throughout research, distribution, and disposal. Stakeholders—including payers and policymakers—increasingly demand transparency and accountability, while investors align funding with environmental, social, and governance criteria. Concurrently, social and ethical imperatives emphasize fair labor practices, community engagement, and equitable access to medicines, reinforcing manufacturers’ commitment to environmental stewardship.

See the chapter

Josep Maria Guiu Segura, Chapter 1 – Creating a culture of sustainability, Editor(s): Dimitrios A. Lamprou, Sustainability in the Manufacturing of Pharmaceuticals, Academic Press, 2025, Pages 1-12, ISBN 9780443289217, https://doi.org/10.1016/B978-0-443-28921-7.00007-5.

This chapter examines the progress and importance of bio-based sustainable polymers as a crucial shift from petroleum-based plastics. With increasing environmental concerns due to plastic pollution and resource depletion, bio-based polymers derived from plants, algae, and microorganisms offer eco-friendly alternatives. Advancements, such as the development of celluloid and the progress in biodegradable plastics like PLA and polyhydroxyalkanoates, have transformed the field. However, challenges such as high costs, limited recycling infrastructure, and scalability are critical issues that hinder their widespread adoption. The bio-based polymer industry is expanding due to the rising demand for eco-friendly solutions. This chapter presents the importance of life cycle assessment in evaluating sustainability as well as current trends, challenges, and prospects. In conclusion, there is a necessity for innovation, regulatory support, and economic feasibility to propel the widespread adoption of bio-based polymers.

See the chapter

Lovely, Navodit Kumar Singh, Avijeet Singh Jaswal, Brajesh Barse, Amit Kumar, Chapter 3 – Bio-based sustainable polymers and materials, Editor(s): Dimitrios A. Lamprou, Sustainability in the Manufacturing of Pharmaceuticals, Academic Press, 2025, Pages 39-60, ISBN 9780443289217, https://doi.org/10.1016/B978-0-443-28921-7.00012-9.

The pharmaceutical industry faces growing pressure to adopt more sustainable manufacturing practices due to increasing environmental concerns and stringent regulatory demands. Traditional manufacturing processes are often resource-intensive, generating significant waste, consuming large amounts of energy, and contributing to a substantial carbon footprint. As the industry looks for innovative solutions to address these challenges, additive manufacturing, particularly three-dimensional (3D) printing, has emerged as a promising alternative. This chapter explores the transformative potential of 3D printing in achieving sustainability within pharmaceutical manufacturing. It examines how 3D printing can reduce material waste, enhance energy efficiency, and enable localized, on-demand production. Key applications in pharmaceuticals, such as personalized medicine, drug delivery systems, and rapid prototyping, are discussed in depth. The chapter also addresses the regulatory landscape, highlighting both challenges and opportunities for adopting 3D printing technologies. Through case studies, the real-world impact of 3D printing on reducing environmental burdens is explored, along with future trends in sustainable pharmaceutical manufacturing.

See the chapter

Atheer Awad, Abdul W. Basit, Chapter 6 – 3D printing the future: sustainable solutions in pharmaceutical manufacturing, Editor(s): Dimitrios A. Lamprou, Sustainability in the Manufacturing of Pharmaceuticals, Academic Press, 2025, Pages 121-153, ISBN 9780443289217, https://doi.org/10.1016/B978-0-443-28921-7.00009-9.

See the full book here

Dimitrios A. Lamprou, Sustainability in the Manufacturing of Pharmaceuticals, ISBN 978-0-443-28921-7, Published 2025, DOI https://doi.org/10.1016/C2023-0-51116-4